1. Home
  2. HOTH vs PTLE Comparison

HOTH vs PTLE Comparison

Compare HOTH & PTLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOTH
  • PTLE
  • Stock Information
  • Founded
  • HOTH 2017
  • PTLE 2013
  • Country
  • HOTH United States
  • PTLE Singapore
  • Employees
  • HOTH N/A
  • PTLE N/A
  • Industry
  • HOTH Biotechnology: Pharmaceutical Preparations
  • PTLE Oil Refining/Marketing
  • Sector
  • HOTH Health Care
  • PTLE Energy
  • Exchange
  • HOTH Nasdaq
  • PTLE Nasdaq
  • Market Cap
  • HOTH 15.6M
  • PTLE 16.4M
  • IPO Year
  • HOTH 2019
  • PTLE 2024
  • Fundamental
  • Price
  • HOTH $1.60
  • PTLE $0.20
  • Analyst Decision
  • HOTH Strong Buy
  • PTLE
  • Analyst Count
  • HOTH 3
  • PTLE 0
  • Target Price
  • HOTH $4.00
  • PTLE N/A
  • AVG Volume (30 Days)
  • HOTH 1.8M
  • PTLE 1.8M
  • Earning Date
  • HOTH 11-11-2025
  • PTLE 01-01-0001
  • Dividend Yield
  • HOTH N/A
  • PTLE N/A
  • EPS Growth
  • HOTH N/A
  • PTLE N/A
  • EPS
  • HOTH N/A
  • PTLE N/A
  • Revenue
  • HOTH N/A
  • PTLE $98,133,646.00
  • Revenue This Year
  • HOTH N/A
  • PTLE N/A
  • Revenue Next Year
  • HOTH N/A
  • PTLE N/A
  • P/E Ratio
  • HOTH N/A
  • PTLE N/A
  • Revenue Growth
  • HOTH N/A
  • PTLE N/A
  • 52 Week Low
  • HOTH $0.65
  • PTLE $0.14
  • 52 Week High
  • HOTH $3.80
  • PTLE $15.78
  • Technical
  • Relative Strength Index (RSI)
  • HOTH 71.15
  • PTLE 55.71
  • Support Level
  • HOTH $1.40
  • PTLE $0.14
  • Resistance Level
  • HOTH $1.80
  • PTLE $0.25
  • Average True Range (ATR)
  • HOTH 0.11
  • PTLE 0.02
  • MACD
  • HOTH 0.04
  • PTLE 0.01
  • Stochastic Oscillator
  • HOTH 68.75
  • PTLE 55.93

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, primarily serving the Asia Pacific market. As a bunker facilitator, the Group's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers in a timely manner; and handling disputes, mainly in relation to quality and quantity issues on marine fuel, if any.

Share on Social Networks: